Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Amphastar Pharmaceuticals Inc AMPH

Healthcare Biotechnology
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed... see more

Current News (NDAQ:AMPH)

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

ACCESS Newswire 13 days ago

Amphastar Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - AMPH

ACCESS Newswire March 4, 2025

AMPH ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Amphastar Pharmaceuticals, Inc. Shareholders Who Lost Money

ACCESS Newswire March 3, 2025

Amphastar Pharmaceuticals, Inc. Being Investigated on Behalf of Amphastar Pharmaceuticals, Inc. Investors. Contact Levi & Korsinsky For Details

ACCESS Newswire February 28, 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

ACCESS Newswire February 27, 2025

AMPH STOCK ALERT: Levi & Korsinsky Notifies Amphastar Pharmaceuticals, Inc. Investors of an Ongoing Investigation

ACCESS Newswire February 27, 2025

AMPH STOCK ALERT: Levi & Korsinsky Notifies Amphastar Pharmaceuticals, Inc. Investors of an Ongoing Investigation

ACCESS Newswire February 26, 2025

Levi & Korsinsky Announces an Investigation on Behalf of Amphastar Pharmaceuticals, Inc. (AMPH) Shareholders Who May Have Been Affected by Fraud

ACCESS Newswire February 25, 2025

Amphastar Pharmaceuticals, Inc. (AMPH) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates

ACCESS Newswire February 24, 2025
View More News ››

Opinion & Analysis (NDAQ:AMPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AMPH)

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) – A Dive

http://beyondspx.com/2024/07/31/amphastar-pharmaceuticals-inc-nasdaqamph-a-diversified-pharmaceutical-powerhouse-delivering-consistent...
MikeTester - August 2, 2024

AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITI

$AMPH Excited to share an article about Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company focusing...
AviseAnalytics - March 13, 2023
View more Bullboard ››

Trillion Energy International Inc.

Trillion Energy International Inc.

Trillion Energy International Inc. is a Canada-based oil and gas producing company that strives to maximize shareholder value ...
View More »